| Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors U Laufs, V La Fata, J Plutzky, JK Liao Circulation 97 (12), 1129-1135, 1998 | 2671 | 1998 |
| Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association JB Buse, HN Ginsberg, GL Bakris, NG Clark, F Costa, R Eckel, V Fonseca, ... Circulation 115 (1), 114-126, 2007 | 2034 | 2007 |
| International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors L Michalik, J Auwerx, JP Berger, VK Chatterjee, CK Glass, FJ Gonzalez, ... Pharmacological reviews 58 (4), 726-741, 2006 | 1279 | 2006 |
| PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells N Marx, GK Sukhova, T Collins, P Libby, J Plutzky Circulation 99 (24), 3125-3131, 1999 | 836 | 1999 |
| The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable … VJ Dzau, EM Antman, HR Black, DL Hayes, JAE Manson, J Plutzky, ... Circulation 114 (25), 2850-2870, 2006 | 781 | 2006 |
| Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells N Marx, U Schönbeck, MA Lazar, P Libby, J Plutzky Circulation research 83 (11), 1097-1103, 1998 | 777 | 1998 |
| Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies T Mazzone, A Chait, J Plutzky The Lancet 371 (9626), 1800-1809, 2008 | 754 | 2008 |
| Discontinuation of statins in routine care settings: a cohort study H Zhang, J Plutzky, S Skentzos, F Morrison, P Mar, M Shubina, A Turchin Annals of internal medicine 158 (7), 526-534, 2013 | 696 | 2013 |
| Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through … N Marx, G Sukhova, C Murphy, P Libby, J Plutzky The American journal of pathology 153 (1), 17-23, 1998 | 685 | 1998 |
| The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia JC Fruchart, F Sacks, MP Hermans, G Assmann, WV Brown, R Ceska, ... The American journal of cardiology 102 (10), 1K-34K, 2008 | 616 | 2008 |
| The pathologic continuum of diabetic vascular disease G Orasanu, J Plutzky Journal of the American College of Cardiology 53 (5S), S35-S42, 2009 | 611 | 2009 |
| NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis JD Brown, CY Lin, Q Duan, G Griffin, AJ Federation, RM Paranal, S Bair, ... Molecular cell 56 (2), 219-231, 2014 | 607 | 2014 |
| Semaglutide and cardiovascular outcomes in obesity without diabetes AM Lincoff, K Brown-Frandsen, HM Colhoun, J Deanfield, SS Emerson, ... New England Journal of Medicine 389 (24), 2221-2232, 2023 | 537 | 2023 |
| PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease N Marx, T Bourcier, GK Sukhova, P Libby, J Plutzky Arteriosclerosis, thrombosis, and vascular biology 19 (3), 546-551, 1999 | 500 | 1999 |
| PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis N Marx, B Kehrle, K Kohlhammer, M Grub, W Koenig, V Hombach, ... Circulation research 90 (6), 703-710, 2002 | 492 | 2002 |
| Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. RM Freeman Jr, J Plutzky, BG Neel Proceedings of the National Academy of Sciences 89 (23), 11239-11243, 1992 | 491 | 1992 |
| Bempedoic acid and cardiovascular outcomes in statin-intolerant patients SE Nissen, AM Lincoff, D Brennan, KK Ray, D Mason, JJP Kastelein, ... New England Journal of Medicine 388 (15), 1353-1364, 2023 | 458 | 2023 |
| Inflammatory pathways in atherosclerosis and acute coronary syndromes J Plutzky The American journal of cardiology 88 (8), 10-15, 2001 | 458 | 2001 |
| Peroxisome proliferator–activated receptors as transcriptional nodal points and therapeutic targets JD Brown, J Plutzky Circulation 115 (4), 518-533, 2007 | 452 | 2007 |
| Retinaldehyde represses adipogenesis and diet-induced obesity O Ziouzenkova, G Orasanu, M Sharlach, TE Akiyama, JP Berger, ... Nature medicine 13 (6), 695-702, 2007 | 443 | 2007 |
